KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+18.06%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$59.8M
AUM Growth
+$59.8M
(+35%)
Cap. Flow
+$9.38M
Cap. Flow
% of AUM
15.68%
Top 10 Holdings %
Top 10 Hldgs %
78.56%
Holding
27
New
6
Increased
6
Reduced
–
Closed
3
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$2.1M |
| 2 |
Ocular Therapeutix
OCUL
|
$1.5M |
| 3 |
Aldeyra Therapeutics
ALDX
|
$1.18M |
| 4 |
SILV
SilverCrest Metals Inc. Common Shares
SILV
|
$1.04M |
| 5 |
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
|
$1.04M |
Top Sells
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$1.07M |
| 2 |
Blackstone
BX
|
$742K |
Sector Composition
| 1 | Healthcare | 71.14% |
| 2 | Materials | 7.31% |
| 3 | Industrials | 3.69% |
| 4 | Financials | 1.83% |
| 5 | Consumer Staples | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aldeyra Therapeutics
ALDX
$351M
| $20.5M | 31.63% | 2,067,160 +119,070 | +6% | +$1.18M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.15M | 9.48% | 450,422 | – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $4.02M | 6.19% | 200,000 +104,609 | +110% | +$2.1M |
|
4
VanEck Gold Miners ETF
GDX
$19B
| $2.97M | 4.58% | 91,850 | – | – |
|
5
Entera Bio
ENTX
$88.1M
| $2.88M | 4.44% | 2,484,275 | – | – |
|
6
Applied Therapeutics
APLT
$71M
| $2.8M | 4.31% | 3,450,000 +1,000,000 | +41% | +$811K |
|
7
Global X Silver Miners ETF NEW
SIL
$2.76B
| $2.76M | 4.25% | 89,700 | – | – |
|
8
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $2.1M | 3.24% | 53,150 | – | – |
|
|
9
Ocular Therapeutix
OCUL
$2.12B
| $1.5M | 2.32% | +200,000 | New | +$1.5M |
|
10
OR Royalties Inc.
OR
$6.05B
| $1.27M | 1.96% | 400,000 +165,000 | +70% | +$525K |
|
11
Thermo Fisher Scientific
TMO
$186B
| $1.21M | 1.87% | 2,100 | – | – |
|
12
Booz Allen Hamilton
BAH
$13.4B
| $1.2M | 1.86% | 13,000 | – | – |
|
13
Visa
V
$683B
| $1.09M | 1.69% | 4,850 | – | – |
|
14
CVS Health
CVS
$92.8B
| $1.08M | 1.66% | 14,500 | – | – |
|
|
SILV
15
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.04M | 1.61% | +170,000 | New | +$1.04M |
|
|
OMGA
16
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.04M | 1.61% | +173,010 | New | +$1.04M |
|
|
SA
17
Seabridge Gold
SA
$1.78B
| $1.04M | 1.6% | 80,000 +39,000 | +95% | +$505K |
|
18
Franco-Nevada
FNV
$36.3B
| $1.02M | 1.57% | +7,000 | New | +$1.02M |
|
19
Altria Group
MO
$113B
| $1.01M | 1.56% | 22,700 | – | – |
|
20
Northrop Grumman
NOC
$84.5B
| $1,000K | 1.54% | +2,165 | New | +$1,000K |
|
21
Altimmune
ALT
$338M
| $734K | 1.13% | 173,864 | – | – |
|
|
IRD
22
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $375K | 0.58% | +100,000 | New | +$375K |
|
|
HOOK
23
DELISTED
HOOKIPA Pharma
HOOK
| $221K | 0.34% | 300,000 +250,000 | +500% | +$184K |
|
|
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – | -150,000 | Closed | -$1.07M |
|
|
25
Blackstone
BX
$134B
| – | – | -10,000 | Closed | -$742K |
|